These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Patenting nanotechnology. Lemley MA Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838 [TBL] [Abstract][Full Text] [Related]
43. From make believe to doomsday eve: or should we patent genes? Schonmann A Med Law; 1998; 17(3):455-76. PubMed ID: 9922633 [TBL] [Abstract][Full Text] [Related]
44. Inventions and patents: a practical tutorial. Tidwell JL; Liotta LA Methods Mol Biol; 2012; 823():391-408. PubMed ID: 22081360 [TBL] [Abstract][Full Text] [Related]
45. Balancing innovation and access to healthcare through the patent system--an Australian perspective. Nicol D Community Genet; 2005; 8(4):228-34. PubMed ID: 16244477 [TBL] [Abstract][Full Text] [Related]
46. Bioethics, biotechnology products and humans: Europe between the skilled Theseus and the Labyrinth-Minotaur's syndrome. Frati P Forum (Genova); 1999; 9(3 Suppl 3):99-105. PubMed ID: 10607854 [TBL] [Abstract][Full Text] [Related]
47. ACOG. Committee opinion: number 277, November 2002. Patients, medicine and the interests of patients: applying general principles to gene patenting. Comittee on Ethics, Comittee on Genetics, The American College of Obstetrician and Gynecologists Obstet Gynecol; 2002 Nov; 100(5 Pt 1):1051-6. PubMed ID: 12434779 [TBL] [Abstract][Full Text] [Related]
48. Ethical questions to ponder in the European stem cell patent debate. Curley D; Sharples A J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135 [TBL] [Abstract][Full Text] [Related]
49. Patent protection: why the first filing needs to be right and how to achieve this. Bajjon A; Schlich GW Pharm Pat Anal; 2017 Nov; 6(6):267-272. PubMed ID: 29022418 [TBL] [Abstract][Full Text] [Related]
50. An overview of a recent court challenge to the protection of biomarkers as intellectual property. Hall SC; Tromp JM; Jortani SA Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704 [TBL] [Abstract][Full Text] [Related]
51. The evolution of gene patents viewed from the United States Patent Office. Mossinghoff GJ Adv Genet; 2003; 50():13-21; discussion 507-10. PubMed ID: 14714684 [TBL] [Abstract][Full Text] [Related]
52. Patent filing strategies: perspectives from the Cooperation Council for the Arab States of the Gulf. Koshy NJ Pharm Pat Anal; 2016 Jul; 5(4):217-26. PubMed ID: 27391111 [TBL] [Abstract][Full Text] [Related]
53. Patent controversies and court cases: cancer diagnosis, therapy and prevention. Fialho AM; Chakrabarty AM Cancer Biol Ther; 2012 Nov; 13(13):1229-34. PubMed ID: 22954683 [TBL] [Abstract][Full Text] [Related]
54. Patent prosecution strategies for biotechnological inventions. Yeh JJ; Fernandez D Assay Drug Dev Technol; 2004 Dec; 2(6):697-702. PubMed ID: 15674028 [TBL] [Abstract][Full Text] [Related]
55. Ethical limitations in patenting biotechnological inventions. Lugagnani V Forum (Genova); 1999; 9(3 Suppl 3):93-8. PubMed ID: 10607853 [TBL] [Abstract][Full Text] [Related]
56. Patenting time-lapse microscopy: the European story. Sterckx S; Cockbain J; Pennings G Reprod Biomed Online; 2014 Feb; 28(2):146-50. PubMed ID: 24369922 [TBL] [Abstract][Full Text] [Related]
57. Patentability of genes: a European Union perspective. Cole P Cold Spring Harb Perspect Med; 2014 Oct; 5(5):a020891. PubMed ID: 25324232 [TBL] [Abstract][Full Text] [Related]
58. Innovations and intellectual property: the case of genomic patenting. Jackson BA J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760 [TBL] [Abstract][Full Text] [Related]
59. Patent border wars: defining the boundary between scientific discoveries and patentable inventions. Holman CM Trends Biotechnol; 2007 Dec; 25(12):539-43. PubMed ID: 17983675 [TBL] [Abstract][Full Text] [Related]